Suchergebnisse - "Xu, Xu Steven"

PubPharm (97)

51

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

enthalten in: Clinical pharmacokinetics | 2017

von Yan, X. | Clemens, P. | Puchalski, T. | +15

52

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2017

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

53

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2017

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

54

Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical pharmacokinetics | 2017

von Xu, X. | Ryan, C. | Stuyckens, K. | +9

CommentIn: Clin Pharmacokinet. 2017 Feb;56(2):211-212. - PMID 27815866

55

Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics : the Perception of Shrinkage and Likelihood Ratio Test

enthalten in: The AAPS journal | 2017

von Xu, X. | Yuan, M. | Yang, H. | +3

56

Response to “The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma”

enthalten in: Clinical pharmacology & therapeutics | 2017

von Xu, X. | Schecter, J. | Jansson, R. | +1

57

Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical pharmacokinetics | 2017

von Xu, X. | Ryan, C. | Stuyckens, K. | +9

58

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2016

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

59

Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test

enthalten in: The AAPS journal | 2016

von Xu, X. | Yuan, M. | Yang, H. | +3

60

Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test

enthalten in: AAPS PharmSci | 2016

von Xu, X. | Yuan, M. | Yang, H. | +3